Intravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndrome
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172861/
Covid19 pneumonia is an extremely rapidly developing disease with a high mortality rate. The main pathogenesis is the acute lung injury that causes ARDS and death. Antioxidants should have a role in the management of these conditions. Appropriate clinical studies and reports demonstrate that a timely administration of high dose IV Vit-C improves the outcome of Covid19 infection.
Possible application of high-dose vitamin C in the prevention and therapy of coronavirus infection
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553131/
Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167497/
High-dose intravenous VC has also been successfully used in the treatment of 50 moderate to severe COVID-19 patients in China. The doses used varied between 10 g and 20 g per day, given over a period of 8–10 h. Additional VC bolus may be required among patients in critical conditions. The oxygenation index was improving in real time and all the patients eventually cured and were discharged [18]. In fact, high-dose VC has been clinically used for several decades and a recent NIH expert panel document states clearly that this regimen (1.5 g/kg body weight) is safe and without major adverse events [19].
上述临试中均使用水溶性维生素C静脉输液。
没有医学基本常识、没干过临床的，才会说静脉输“脂质体”，或“脂化”类物质直接进入血行。这些东东会形成栓塞……致命。
